Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Neoplasms 6 Neoplasm Metastasis 2 Colorectal Neoplasms 2 Solid Tumor 1 Sarcoma, Ewing 1 Rhabdomyosarcoma 1 Recurrence 1 Pancreatic Cancer Non-resectable 1 Pancreatic Adenocarcinoma 1 Osteosarcoma 1 Neuroblastoma 1 Gastrointestinal Neoplasms 1 Borderline Resectable Pancreatic Cancer 1 Biliary Tract Neoplasms 1 Advanced Esophageal Squamous Cell Cancer 1

Interventions

irinotecan sucrosofate 1 folfirinox 1 Taxes 1 Surgical Procedures, Operative 1 Radiotherapy 1 Radiosurgery 1 Oxaliplatin 1 Leucovorin 1 Gemcitabine 1 Folfox protocol 1 Fluorouracil 1 Albumin-Bound Paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Pancreatic Adenocarcinoma × irinotecan sucrosofate × Clear all

NCT03528785 2021-08-02

nITRo

Centro Ricerche Cliniche di Verona

Phase 2 Unknown

Gastrointestinal

Pancreatic Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡